Tags: Drug.

Apixaban (INN trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.

Apixaban.svg
ATC prefix
B01
ATC suffix
AF02
CAS number
503612-47-3
ChEBI
72296
DrugBank
DB07828
FDA UNII code
3Z9Y7UWC1J
IUPAC name
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-45-dihydropyrazolo[54-c]pyridine-3-carboxamide
PubChem
10182969

Loading...

This page contains content from the copyrighted Wikipedia article "Apixaban"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.